Stereotactic body radiotherapy (SBRT) significantly improved progression- free survival for patients with oligoprogressive, metastatic lung cancer but not breast cancer.
Stereotactic body radiation therapy (SBRT) significantly improved progression-free survival in oligoprogressive, metastatic lung cancer, but not breast cancer.